|
KIAA1191 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.07509999791588E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.63089996852284E-09 |
| Normal-vs-Stage2 |
5.47849999810168E-08 |
| Normal-vs-Stage3 |
1.86849999994632E-06 |
| Normal-vs-Stage4 |
4.81759999670928E-08 |
| Stage1-vs-Stage2 |
4.638600E-01 |
| Stage1-vs-Stage3 |
2.694500E-02 |
| Stage1-vs-Stage4 |
6.620000E-01 |
| Stage2-vs-Stage3 |
2.137800E-01 |
| Stage2-vs-Stage4 |
9.196800E-01 |
| Stage3-vs-Stage4 |
1.488380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.07109999758492E-08 |
| Normal-vs-AfricanAmerican |
1.26060000216199E-08 |
| Normal-vs-Asian |
2.214300E-02 |
| Caucasian-vs-AfricanAmerican |
7.635200E-01 |
| Caucasian-vs-Asian |
4.388800E-01 |
| AfricanAmerican-vs-Asian |
4.693800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.50110001785021E-09 |
| Normal-vs-Female |
1.92010000121812E-08 |
| Male-vs-Female |
3.856000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.95859994468162E-09 |
| Normal-vs-Extreme_Weight |
5.59339996542008E-09 |
| Normal-vs-Obese |
1.13050000472015E-08 |
| Normal-vs-Extreme_Obese |
6.63639999620713E-08 |
| Normal_Weight-vs-Extreme_Weight |
6.827400E-01 |
| Normal_Weight-vs-Obese |
9.684200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.977600E-01 |
| Extreme_Weight-vs-Obese |
6.111400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.939200E-01 |
| Obese-vs-Extreme_Obese |
6.614200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.75880000008455E-07 |
| Normal-vs-Age(41-60Yrs) |
3.28670000104836E-08 |
| Normal-vs-Age(61-80Yrs) |
3.10990000418343E-09 |
| Normal-vs-Age(81-100Yrs) |
3.52160000050006E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.970000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.513000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.582200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.385000E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.657400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.690400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.71519995376224E-09 |
| Normal-VS-Type2 PRCC |
6.75260000027045E-07 |
| Normal-VS-KIRP CIMP |
2.09640005355283E-09 |
| Normal-VS-Unclassified PRCC |
8.36140001680974E-09 |
| Type1 PRCC-VS-Type2 PRCC |
2.0209999999965E-05 |
| Type1 PRCC-VS-KIRP CIMP |
6.014800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.137000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.276040E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
5.121000E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
2.755800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.61530000486465E-08 |
| Normal-vs-N1 |
3.43110000411428E-08 |
| Normal-vs-N2 |
2.03929999997854E-06 |
| N0-vs-N1 |
8.848200E-01 |
| N0-vs-N2 |
5.879600E-01 |
| N1-vs-N2 |
4.566600E-01 |
|
|
